galactose has been researched along with End Stage Liver Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jalanko, H; Kosola, S; Lampela, H; Pakarinen, MP | 1 |
1 other study(ies) available for galactose and End Stage Liver Disease
Article | Year |
---|---|
Galactose half-life is a useful tool in assessing prognosis of chronic liver disease in children.
Topics: Adolescent; Biliary Atresia; Child; Child, Preschool; Cohort Studies; End Stage Liver Disease; Galactose; Humans; Infant; Liver Failure; Liver Transplantation; Predictive Value of Tests; Prognosis; ROC Curve; Sensitivity and Specificity; Treatment Outcome | 2012 |